African Pharmaceutical Market Analysis By Therapeutic Class , By Drug Categories, By Inhalants, By Anabolic Steroids & by Region with Forecast 2017-2030

African Pharmaceutical Market Outlook | 2023 Edition

Africa is the only pharmaceutical market where genuinely high growth is still achievable, value of Africa’s pharmaceutical industry jumped to USD 28.56 billion in 2017 from just USD 5.5 billion a decade earlier. That growth is continuing at a rapid pace: we predict the market will be worth USD 56 billion to USD 70 billion by 2030. It is opportunistic for multinationals and pharmaceutical companies seeking new sources of growth as developed markets stagnate while patients will also gain access to medicines previously unavailable on the continent.

The African pharmaceutical industry presents significant growth opportunities, driven by factors such as population growth, urbanization, and increasing demand for healthcare services. The continent's population is projected to reach 2.5 billion by 2050, with a growing middle class that has increased access to healthcare. The African pharmaceutical market is also relatively underdeveloped compared to other regions, presenting significant opportunities for investment and growth. African pharmaceutical industry is a rapidly growing sector that presents significant opportunities for investment and growth. The industry is driven by factors such as population growth, economic development, and increasing demand for healthcare services. The market is also becoming increasingly competitive, with a growing number of pharmaceutical companies investing in the region. However, the industry still faces challenges such as inadequate infrastructure, limited access to funding, and regulatory barriers. Overall, the African pharmaceutical industry is poised for further growth and development in the coming years, as more players enter the market and investment in healthcare infrastructure increases.

Africa Pharmaceutical Market Segmentation

On the Basis of Therapeutic Class

• Oncology
• Central Nervous System
• Reproductive Medicine & Women’s Health
• Cardiovascular
• Metabolic
• Orhthopaedics
• Endocrine
• Antiviral
• Diabetes
• Antibiotic
• Gastrointestinal
• Genitourinary
• Respiratory
• Ophthalmic
• Antifungal
• Musculoskeletal
• Hematology
• Radiology
• Dermatology
• Phototherapy
• Antihelminthic

On the Basis of Drug Categories

• Stimulants

Cocaine

Methamphetamines

Amphetamines

Ritalin

Cylert

• Inhalants

Glues

Paint thinner

Gasoline

Laughing gas

Aerosol sprays

• Cannabinoids

Hashish

Marijuana

• Depressants

Barbiturates

Benzodiazepines

Flunitrazepam

GHB (Gamma-hydroxybutyrate)

Methaqualone

Alcohol

Tranquillisers

• Opioids & Morphine Derivatives

Codeine

Fentanyl and fentanyl analogs

Heroin

Morphine

Opium

Oxycodone HCL

Hydrocodone bitartrate, acetaminophen

• Anabolic Steroids

Anadrol

Oxandrin

Durabolin

Stanozol

Dianabol

• Hallucinogens

LSD (lysergic acid diethylamide)

Mescaline

Psilocybin

Magic Mushrooms

• Prescription Drugs

Opiods: Codeine, Oxycodone, Morphine

Central nervous system depressants: barbiturates, benzodiazepines

Stimulants: dextroamphetamine, methylphenidate

On the Basis of Distribution Channel

• Pharmacy/OTC Stores
• Retail Stores
• Online Channel

On the Basis of Countries

• South Africa Pharmaceutical Market
• Nigeria Pharmaceutical Market
• Morocco Pharmaceutical Market
• Kenya Pharmaceutical Market
• Ghana Pharmaceutical Market
• Algeria Pharmaceutical Market
• Tunisia Pharmaceutical Market
• Tanzania Pharmaceutical Market
• Sudan Pharmaceutical Market
• Rest of Africa Pharmaceutical Market

Market Dynamics

The African pharmaceutical industry has experienced significant growth in recent years, driven by factors such as increasing demand for healthcare, population growth, and economic development. As shown in Table, the South African pharmaceutical market is the largest in Africa, with a market size of USD 3.9 billion in 2021. However, other African countries such as Egypt, Algeria, Morocco, Nigeria, and Tunisia also have significant pharmaceutical markets, with market sizes ranging from USD 0.3 billion to USD 2.6 billion.

Generic drugs play a crucial role in the African pharmaceutical industry, providing affordable alternatives to branded drugs. As shown in Table, the North African region has the largest generic drugs market in Africa, with a market size of USD 3.0 billion in 2021. This is followed by the East African, West African, Central African, and Southern African regions. The increasing use of generic drugs in Africa is expected to drive further growth in the pharmaceutical industry, as more people gain access to essential medicines.

Africa’s pharmaceutical markets are growing in every segment, given that between 2017 and 2030, prescription drugs are forecast to grow at a compound annual growth rate of 6.5%, generics at 10%, over-the-counter medicines at 7.1%, and medical devices at 12.1%. Increasing urbanisation, healthcare capacity and supportive business environment are the drivers of the Africa pharmaceutical market. For early movers in order to pursue competitive advantage requires focus on pockets of growth like much of the opportunity lies not at country level, but in cities. According to the analysis, 37% of African consumers are concerted in 30 cities, which will have more consuming households than Australia and the Netherlands combined by 2025. Addressing supply and distribution challenges, building stronger team and forging partnerships are the “to win strategies” as global pharmaceutical companies need local business partners like manufacturers, packaging companies, and distributor in order to help them navigate the continent’s many markets, with their widely varying consumer preferences, price points, manufacturing, and distribution infrastructures.

The market research report titled “Africa Pharmaceuticals Market” by Goldstein Market Intelligence is the comprehensive review of market drivers, trends, opportunities, issues and restraints in addition to This report analyses the Africa markets for pharmaceuticals in USD Million. The report provides separate comprehensive analytics for the South Africa, Tanzania, Algeria, Sudan, Kenya, Morocco, Ghana and Tunisia pharmaceuticals market. The country analysis provides insights about the target and potential markets for pharmaceuticals across the Africa continent.

Top 10 African Countries by Pharmaceutical Market Size (2021)

African Generic Drugs Market by Region (2021)

Generic drugs play a crucial role in the African pharmaceutical industry, providing affordable alternatives to branded drugs. As shown in Table, the North African region has the largest generic drugs market in Africa, with a market size of USD 3.0 billion in 2021. This is followed by the East African, West African, Central African, and Southern African regions. The increasing use of generic drugs in Africa is expected to drive further growth in the pharmaceutical industry, as more people gain access to essential medicines.

Covered in thisA frican Pharmaceutical Market report

The market study includes annual estimates and forecast data on the basis of historical market analysis (2016-2017), current market analysis (2018) & forecast analysis (2019-2030) are derived from primary and secondary research. The research reports covers the Trade Data (Export & Import), By value & volume, Sales (in USD), Investment Flow Analysis, Pipeline Products Insights, Competitive Analysis of Players which includes mergers & acquisition activities, financial analysis, Start-ups associated, global presence, patents, product portfolio, brand recognition & market competition.

COVID-19 imapct on "African Pharmaceutical Market"

Impact of COVID-19 Outbreak on African Pharmaceutical Industry, Manufacturers, Contract Manufacturers Suppliers and Recovery Strategy. A complete detailed chapter of 50-70 pages which includes the data and information focused on impacts of the pandemic on the Nigerian Pharma Industry. It also showcases the expected recovery schedule and losses in the industry and other various major factors. 

Market Share by Key Players 

Market Study Pattern

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

For a detailed overview, send here request for market report sample.